EXCLUSIVE: NCGR Makes Staff Cuts, New CEO Defines Post-Noncompete Plan | GenomeWeb

NEW YORK, July 27 - A month after taking the helm as interim CEO of the National Center for Genome Resources, Miguel Rios eliminated eight staff positions yesterday. In an interview Friday with GenomeWeb, Rios said most of the layoffs were made in administrative staff and that no technical or scientific jobs were cut. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.